Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ferrara Ophthalmics is a specialized medical device company focused on the treatment of corneal diseases, most notably keratoconus. The company is best known for the development and commercialization of the Ferrara Ring, an intrastromal corneal ring segment (ICRS) designed to flatten the cornea and improve visual acuity. Founded by Dr. Paulo Ferrara, the company has established itself as a global leader in the surgical management of corneal ectasia, providing a reversible alternative to corneal transplantation. Its products are used by ophthalmic surgeons worldwide and are supported by extensive clinical research and long-term follow-up data.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ferrara.